These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 7608802)

  • 1. Use of glucagon to treat neonatal low-output congestive heart failure after maternal labetalol therapy.
    Stevens TP; Guillet R
    J Pediatr; 1995 Jul; 127(1):151-3. PubMed ID: 7608802
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adverse neonatal effects of maternal labetalol treatment.
    Crooks BN; Deshpande SA; Hall C; Platt MP; Milligan DW
    Arch Dis Child Fetal Neonatal Ed; 1998 Sep; 79(2):F150-1. PubMed ID: 9828745
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neonatal side effects of maternal labetalol treatment in severe preeclampsia.
    Heida KY; Zeeman GG; Van Veen TR; Hulzebos CV
    Early Hum Dev; 2012 Jul; 88(7):503-7. PubMed ID: 22525036
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neonatal adaptation in hypertensive pregnancy--a study of labetalol vs hydralazine treatment.
    Hjertberg R; Faxelius G; Lagercrantz H
    J Perinat Med; 1993; 21(1):69-75. PubMed ID: 8487154
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neonatal haemodynamic effects following foetal exposure to labetalol in hypertensive disorders of pregnancy.
    Thewissen L; Pistorius L; Baerts W; Naulaers G; Van Bel F; Lemmers P
    J Matern Fetal Neonatal Med; 2017 Jul; 30(13):1533-1538. PubMed ID: 27294851
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intravenous labetalol and intravenous dihydralazine in severe hypertension in pregnancy.
    Garden A; Davey DA; Dommisse J
    Clin Exp Hypertens B; 1982; 1(2-3):371-83. PubMed ID: 7139977
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neonatal adrenergic blockade following single dose maternal labetalol administration.
    Klarr JM; Bhatt-Mehta V; Donn SM
    Am J Perinatol; 1994 Mar; 11(2):91-3. PubMed ID: 8198664
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Cardiac arrest in newborn of mother treated with labetalol].
    Sala X; Monsalve C; Comas C; Botet F; Nalda MA
    Rev Esp Anestesiol Reanim; 1993; 40(3):146-7. PubMed ID: 8516525
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of antihypertensive therapy in mild to moderate pregnancy-induced hypertension: a prospective randomized study comparing labetalol with alpha methyldopa.
    Molvi SN; Mir S; Rana VS; Jabeen F; Malik AR
    Arch Gynecol Obstet; 2012 Jun; 285(6):1553-62. PubMed ID: 22249781
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Malignant ventricular arrhythmias in eclampsia: a comparison of labetalol with dihydralazine.
    Bhorat IE; Naidoo DP; Rout CC; Moodley J
    Am J Obstet Gynecol; 1993 Apr; 168(4):1292-6. PubMed ID: 8475977
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association between labetalol use for hypertension in pregnancy and adverse infant outcomes.
    Xie RH; Guo Y; Krewski D; Mattison D; Walker MC; Nerenberg K; Wen SW
    Eur J Obstet Gynecol Reprod Biol; 2014 Apr; 175():124-8. PubMed ID: 24502872
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A randomized, double-blind trial of oral nifedipine and intravenous labetalol in hypertensive emergencies of pregnancy.
    Vermillion ST; Scardo JA; Newman RB; Chauhan SP
    Am J Obstet Gynecol; 1999 Oct; 181(4):858-61. PubMed ID: 10521742
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The use of labetalol for attenuation of the hypertensive response to endotracheal intubation in preeclampsia.
    Ramanathan J; Sibai BM; Mabie WC; Chauhan D; Ruiz AG
    Am J Obstet Gynecol; 1988 Sep; 159(3):650-4. PubMed ID: 3421264
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Half-life of maternal labetalol in a premature infant.
    Haraldsson A; Geven W
    Pharm Weekbl Sci; 1989 Dec; 11(6):229-31. PubMed ID: 2616255
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Severe adverse effects of maternal labetalol in a premature infant.
    Haraldsson A; Geven W
    Acta Paediatr Scand; 1989 Nov; 78(6):956-8. PubMed ID: 2603724
    [No Abstract]   [Full Text] [Related]  

  • 16. Intrapartum labetalol for the treatment of maternal and fetal thyrotoxicosis.
    Bowman ML; Bergmann M; Smith JF
    Thyroid; 1998 Sep; 8(9):795-6. PubMed ID: 9777752
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of maternal labetalol on the newborn infant.
    Macpherson M; Broughton Pipkin F; Rutter N
    Br J Obstet Gynaecol; 1986 Jun; 93(6):539-42. PubMed ID: 3730323
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nifedipine versus labetalol in the treatment of hypertensive disorders of pregnancy.
    Giannubilo SR; Bezzeccheri V; Cecchi S; Landi B; Battistoni GI; Vitali P; Cecchi L; Tranquilli AL
    Arch Gynecol Obstet; 2012 Sep; 286(3):637-42. PubMed ID: 22581388
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined alpha- and beta-receptor inhibition in the treatment of hypertension.
    Prichard BN
    Drugs; 1984; 28 Suppl 2():51-68. PubMed ID: 6151891
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of maternal labetalol on the newborn infant.
    Munshi UK; Deorari AK; Paul VK; Singh M
    Indian Pediatr; 1992 Dec; 29(12):1507-12. PubMed ID: 1291496
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.